LEADER 05114nam 2201261z- 450 001 9910639989003321 005 20231214133528.0 010 $a3-0365-5885-3 035 $a(CKB)5470000001633464 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/95836 035 $a(EXLCZ)995470000001633464 100 $a20202301d2022 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aDevelopmental Exposure to Environmental Contaminants 210 $aBasel$cMDPI - Multidisciplinary Digital Publishing Institute$d2022 215 $a1 electronic resource (256 p.) 311 $a3-0365-5886-1 330 $aDevelopment provides an especially sensitive window whereby environmental contaminants can have significant and lasting effects on the morphology and function of many organs and systems. The importance of understanding developmental effects of environmental contaminants extends not only to developmental stages, but also to encompass the hypotheses of the developmental or fetal origins of adult disease. Such effects of environmental contaminants during development extend to health outcomes that can persist in adulthood, first become apparent in adulthood, or manifest in adulthood but only after a second hit/stressor. The diverse nature of possible environmental contaminants, ranging from persistent organic pollutants to emerging contaminants of concern, along with the diverse range of health implications, including autism, diabetes, cancer, infertility, and lower urinary tract function, make understanding developmental effects of environmental contaminants an ever growing and important field of study.This Special Issue aims to explore a variety of topics in line with the aims and scope of Toxics. Specifically, topics related to the developmental effects of environmental contaminants and/or their metabolites on the molecular, cellular, tissue, organ, organ system or organism, including mechanisms of toxicity, metabolism, risk assessment and management, as well as multiple stressor impacts in the context of aging or disease progression following developmental exposures. 606 $aMedicine$2bicssc 606 $aMedical toxicology$2bicssc 610 $aarsenic 610 $asynaptic transmission 610 $along-term potentiation 610 $ahippocampus 610 $adevelopment 610 $alower urinary tract 610 $abladder 610 $ainflammation 610 $aPOPs 610 $adevelopmental basis of adult disease 610 $amultigenerational 610 $atoxicants 610 $abronchopulmonary dysplasia 610 $atherapeutics 610 $alung development 610 $aselective serotonin reuptake inhibitor 610 $aperinatal mortality 610 $aneonatal morbidity 610 $afluoxetine 610 $asertraline 610 $aendocrine-disrupting chemicals (EDC) 610 $aAroclor 1221 (A1221) 610 $aPCBs 610 $avinclozolin 610 $asocial behavior 610 $asex differences 610 $atransgenerational 610 $aepigenetic 610 $aendocrine-disrupting chemical (EDC) 610 $apolychlorinated biphenyl (PCB) 610 $amating behavior 610 $apaced mating 610 $aultrasonic vocalization (USV) 610 $aestradiol 610 $atriclosan 610 $atriclocarbon 610 $adetergents 610 $a4-nonylphenol 610 $aDanio rerio 610 $azebrafish 610 $aenvironmental toxicity 610 $aaquatic environment 610 $aground water chemicals 610 $alower urinary tract dysfunction 610 $alower urinary tract symptoms 610 $aBPH 610 $aprostate 610 $aaxonal growth 610 $adevelopmental neurotoxicity 610 $aneuronal morphogenesis 610 $aPBDE 610 $areactive oxygen species 610 $athyroid hormone 610 $apesticides 610 $aprebiotic 610 $aintestinal dysbiosis 610 $aperigestational 610 $adysmetabolism 610 $arisk factor 610 $abehavior 610 $achemical screening 610 $aliterature comparison 610 $adevelopmental toxicity 610 $anegative control 610 $apositive control 610 $arapid testing 610 $aPFAS 610 $aPFAS mixtures 610 $aepigenetics 610 $amicroglia 610 $avalproic acid 610 $aprimary motor cortex 615 7$aMedicine 615 7$aMedical toxicology 700 $aStietz$b Kimberly Keil$4edt$01328327 702 $aBaker$b Tracie$4edt 702 $aPlavicki$b Jessica$4edt 702 $aStietz$b Kimberly Keil$4oth 702 $aBaker$b Tracie$4oth 702 $aPlavicki$b Jessica$4oth 906 $aBOOK 912 $a9910639989003321 996 $aDevelopmental Exposure to Environmental Contaminants$93038479 997 $aUNINA